Abbreviations {#nomen0010}
=============

*T. hemsleyanum*

:   *Tetrastigma hemsleyanum* Diels et Gilg

TCM

:   Traditional Chinese Medicine

UPLC-ESI-Q-TOF-MS/MS

:   Ultra high performance liquid chromatography tandem triple quadrupole time of flight mass spectrometry

MIC

:   minimum inhibitory concentration

GSH

:   glutathione

MDA

:   malondialdehyde

NF-κB

:   nuclear factor-κB

5-HT

:   5-hydroxytryptamine

NE

:   norepinephrine

DA

:   dopamine

PGE2

:   prostaglandin E2

MAPK

:   mitogen-activated protein kinase

LPS

:   lipopolysaccharide

*C.elegans*

:   *Caenorhabditis elegans*

TNF-α

:   tumor necrosis factor-alpha

IL-1β

:   interleukin-1 beta

IL-6

:   interleukin 6

IL-12p40

:   interleukin 12 subunit p40

sTNF-R1

:   soluble TNF receptors 1

IL-10

:   interleukin 10

IL-1

:   interleukin 1

IL-4

:   interleukin 4

iNOS

:   inducible NO synthase

TLR4

:   Toll-like receptor 4

MD-2

:   myeloid differentiation factor-2

MyD88

:   myeloid differentiation protein 88

JNK

:   c-Jun N-terminal kinase

GPT

:   glutamic-pyruvic transaminase

GOT

:   glutamic-oxalacetic transaminase

ALP

:   alkaline phosphatase

SOD

:   superoxide dismutase

ALT

:   alanine aminotransferase

AST

:   aspartate aminotransferase

HA

:   hyaluronan

LN

:   laminin

T-BiLi

:   total bilirubin

TP

:   total protein

IFN-γ

:   interferon-gamma

IgA

:   immunoglobulin A

S-IgA

:   secretory immunoglobulin A

EMT

:   Epithelial-mesenchymal transition

MMPs

:   matrix metalloproteinase

TIMPs

:   matrix-metallo proteinase

Cyt-c

:   Cytochrome *c*

CAT

:   catalase

GSH-Px

:   glutathione peroxidase

Tregs

:   regulatory T cells

TGF-β

:   transforming growth factor beta

COX2

:   cyclooxygenase 2

Foxp3

:   forkhead/winged helix transcription factor gene

PDL

:   population doubling time

T-AOC

:   total antioxidant capacity

CCl~4~

:   carbon tetrachloride

CEF

:   chicken embryo fibroblast

HVJ

:   Hemagglutinating virus of Japan

VSV

:   vesicular stomatitis virus

A

:   alkali-containing extract of *T. hemsleyanum*

F

:   ketone-containing extract of *T. hemsleyanum*

S~1~

:   crude extract of *T. hemsleyanum*

S~2~

:   crude extract of *T. hemsleyanum*

PEF

:   Petroleum ether extractions of *T. hemsleyanum* ethanol extract

CFF

:   Chloroform extractions of *T. hemsleyanum* ethanol extract

EAF

:   ethyl acetate extractions of *T. hemsleyanum* ethanol extract

BAF

:   n-butanol extractions of *T. hemsleyanum* ethanol extract

1. Introduction {#sec1}
===============

*Tetrastigma hemsleyanum* Diels et Gilg (*T. hemsleyanum*), mostly known as "San ye qing", is a kind of folk plant. Because of its slow growth, it usually takes 3--5 years to meet the requirements of commercial medicinal materials, so it is a precious perennial medicinal resource. It mainly grows in the eastern, central, southern and south-western provinces of China, such as Zhejiang, Jiangsu Guangxi, Fujian and Yunnan provinces ([@bib64]). *T. hemsleyanum* is known worldwide as sources of phytotherapeutics, which have been used for the treatment of conditions related to inflammatory and immune response, and been recorded based on clinical trials or the use of animal models ([@bib107]). As an edible plant, the leaves of *T. hemsleyanum* consumed as a functional tea or dietary supplement for its health benefits, such as improving the immune system of the body ([@bib79]), while the aerial parts of *T. hemsleyanum* developed as potential new traditional chinese medicine (TCM) preparations ([@bib26]). The root tubers of *T. hemsleyanum* are extensively used either alone or in combination with other herbal medicines in TCM clinics for the treatment of children with fever, convulsion, pneumonia, asthma, rheumatism, hepatitis, menstrual disorders, scrofula, and pharynx pain ([@bib80]; [@bib3]). Therefore, it was called as "natural plant antibiotic" according to its wide spectrum of prominent bactericidal and anti-inflammatory activities. In February 2018, *T. hemsleyanum* was awarded as the new "eight famous kinds of TCM in Zhejiang province", meant that it has become a key object of industrialization development of Zhejiang\'s dominant large varieties of medicinal materials.

In 2019, COVID-19 broke out and has caused more than 4600 deaths in China, and infection cases have been reported in more than 200 countries. Hua Shi Xuan Fei mixture (Approval number of Zhejiang medicine, Z20200026000), which is mainly composed of *T. hemsleyanum*, has been approved by Zhejiang Provincial Drug Administration for clinical treatment of COVID-19. Futhermore, the modern pharmacological studies had shown that *T. hemsleyanum* also had effects of anti-inflammatory ([@bib37]), antioxidant ([@bib30]), antivirus ([@bib11]), antitumor ([@bib48]) antipyretic ([@bib113]), anti-hepatic injury ([@bib58]), immunomodulatory ([@bib100]), anti-bacterial ([@bib6]), hypoglycemic ([@bib72], [@bib73]) etc. Numerous reports have demonstrated that the biological activities of *T. hemsleyanum* are attributed to its many chemical components ([@bib23]). Wang has reported isolated alkaloids from the aerial parts of *T. hemsleyanum* ([@bib82]). Ru extracted a novel polysaccharide TDGP-3 from *T. hemsleyanum* with a molecular weight of 3.31 × 10^5^ Da by enzymolysis-ultrasonic assisted extraction method ([@bib70], [@bib71]). Large amounts of flavonoids were found in leaves, aerial parts and root tubers of *T. hemsleyanum* ([@bib105], [@bib106]; [@bib10]; [@bib116]). In addition, *T. hemsleyanum* also contains a variety of functional components, such as organic acids ([@bib32]), phenolic acids ([@bib51]), minerals ([@bib17]), amino acids ([@bib22]) etc.

In recent years, wild resources of *T. hemsleyanum* have been overexploited and now are on the verge of extinction due to its multiple medicinal values coupled with the strict requirements of the growing environments. In 2011, it was listed in the preferentially protected crop germplasm resources of Zhejiang province. Based on our team\'s preliminary research ([@bib68], [@bib69], [@bib66], [@bib65]; [@bib66], [@bib67]; [@bib46]), we comprehensively summarized and analyzed the domestic and overseas research progress on traditional uses, the bioactive components of *T. hemsleyanum*, pharmacological activities, toxicology with the aim of providing guidance for in-depth research and reference for its development and utilization.

2. Materials and methods {#sec2}
========================

The available information about the traditional uses, phytochemicals and pharmacological properties of *T. hemsleyanum* was searched via Web of Science, Google Scholar, PubMed, Science Direct, China National Knowledge Infrastructure (CNKI), and Springer search using Chinese or English as the retrieval languages. The keywords used include *T. hemsleyanum*, root tubers of *T. hemsleyanum*, *Radix Tetrastigma*, traditional uses, phytochemistry, bioactive components, pharmacological activities, toxicology, and other related words. All references were from experimental studies and published prior to April 2020 were reviewed. All chemical structures were drawn using ChemDraw Pro 7.0 software.

3. Botanical characteristics {#sec3}
============================

*T. hemsleyanum* is a perennial grass climbing vine with longitudinal ribs, glabrous or sparsely pilose. It is usually grown in a cool and humid environment, and the main soil type is yellow soil or yellow brown soil with rich humus. The optimum pH is between 4.29 and 7.65. The root tubers are thick, spindle shaped or elliptical, and single or several are connected into a string of beads, generally 1.5--3 cm long and 0.7--1.5 cm in diameter ([Fig. 1](#fig1){ref-type="fig"} ). The epidermis of the root tubers is tan, and most of them are smooth, a few of them have folds and lenticel like protuberances, some of them have depressions, in which there are residual tan roots, hard and brittle, with a flat and rough section. The stem of *T. hemsleyanum* is thin and weak with longitudinal rhombus, rooting on the lower node. Palmate compound leaves alternate, leaflets are lanceolate, oblong or ovate lanceolate. The leaflets are 3--10 cm long and 1.5--3 cm wide, with a tapered tip and a wedge-shaped or round base. The flowers of *T. hemsleyanum* are small, yellow green and ovate. The flowering stage of *T. hemsleyanum* ranges from April to June, and the fruit phase is normally from August to November. When the flower withered, it will form a small green round fruit with the size of millet. When it is mature, the fruit will turn from green to red, the berries are spherical and soft spherical.Fig. 1The aerial part (A), root tuber (B) and raw herb (C) of *T. hemsleyanum*.Fig. 1

4. Traditional uses {#sec4}
===================

*T. hemsleyanum*, belonging to the family Vitaceae, was firstly recorded in Ben Cao Gang Mu (Ming Dynasty, A.D. 1590). The aliases of Sanyeqing include Shi Hou Zi, Shi Bao Zi, Shi Lao Shu, Lan Shan Hu, Lei Dan Zi, Po Shi Zhu, Tu Jing Wan, Sou Jia Feng, San Ye Dui, golden wire hanging gourd, golden bell, golden wire hanging potato, etc. The root tubers or whole grass of *T. hemsleyanum* traditionally and ethnically used as a medicine for a long time, it has been recorded in multiple ancient books of TCM, such as Zhi Wu Ming Shi Tu Kao (Qing Dynasty, [@bib93]), Jiangxi herbal medicine, Common folk herbal medicine in Zhejiang. All of these ancient works described the effects of *T. hemsleyanum* were heat-clearing, toxicity-removing, dyspnea-relieving, promoting blood circulation and pain relief, thus, it can be applied to cure febrile convulsion, pneumonia, bronchitis, pharyngitis, sore throat, acute and chronic hepatitis, rheumatic arthralgia, viral meningitis, bruise, eczema, insect and snake bite, poor joint flexure and extension, irregular menstruation of women ([@bib60]). In the TCM culture, the properties of *T. hemsleyanum* was described as bitter and acrid in taste, cool in nature which recorded in dictionaries of traditional Chinese medicine and Zhong Hua Ben Cao ([@bib74]). The channel tropism was lung, heart, liver and kidney meridians.

Decocting with water or mashing for external application are the traditional possess methods of *T. hemsleyanum*. Considering its extensive traditional effects, many prescriptions containing *T. hemsleyanum* have been passed down from generation to generation, and have been well supported and clarified by modern pharmacological studies. Excitingly, it has reported that Jinlian disinfection drink containing san ye qing combined with interferon can treat Covid-19 ([@bib28]). Jinqi Tablet, made up of san ye qing, astragalus and ginsenoside, was used to treat 120 cases of malignant tumor, 52 cases were completely relieved, 42 cases were partially relieved, the total effective rate was 78.33% ([@bib90]). Moreover, Zhonggan mixture, including san ye qing, could improve the quality of life and prolong the survival time of patients with stage Ⅲ primary liver cancer ([@bib38]). In addition, it has been used in the treatment of common gynecological diseases such as blood avalanche and leucorrhea ([@bib25]), and it also has a good effect on measles complicated with pneumonia, anal fissure, chronic bronchitis and mosquito bites ([@bib36]).

5. Chemical compounds of *T.hemsleyanum* {#sec5}
========================================

The chemical constituents of *T. hemsleyanum* have been widely investigated ([@bib77]; [@bib76]; [@bib121]; [@bib105], [@bib106]; [@bib22]; [@bib18]; [@bib2]; [@bib13], [@bib14]; [@bib13]), a total of one hundred and forty-two compounds have been isolated and identified from *T. hemsleyanum* until now. The information about compound name, molecular weight, compound formula, detection method, analysis sample is summarized in [Table 1](#tbl1){ref-type="table"} .Table 1The prescriptions and traditional uses of *T. hemsleyanum* in China.Table 1Prescriptions nameMain compositionTraditional useUsageReferencesQingteng Fengshi Jiu*T. hemsleyanum*, *Parabarium chunianum* Tsiang, *Zanthoxylum nitidum* (Roxb.) DC.Treatment of joint pain, wind cold dampness arthralgiaOral administration, 15--25 mL once, 3 times a dayMinisterial standardQufengshi Yaojiu*T. hemsleyanum*, *Deeringia amaranthoides* (Lam.) Merr, *Blumea aromatica* (Wall.) DC.Treatment of arthralgia syndrome, rheumarthritis, rheumatoid arthritis, scapulohumeral periarthritisOral administration, 25 mL once, 3 times a dayMinisterial standardHuatuo Fengtongbao capsule*T. hemsleyanum*, *Deeringia amaranthoides* (Lam.) Merr, *Zanthoxylum nitidum* (Roxb.) DC, *Panax notoginseng* (Burk.) F.H. ChenTreatment of arthralgia syndrome, rheumarthritis, rheumatoid arthritis, scapulohumeral periarthritis, joint pain, muscular constrictureOral administration, 2 capsules once, 3 times a dayMinisterial standardSanyeqing Gypsum Decoction*T. hemsleyanum*, Gypsum, *Lonicera japonica* Thunb, *Houttuynia cordata* Thunb, *Ophiopogon japonicus* (Linn. f.) Ker-GawlTreatment of infantile hyperpyretic convulsionOne dose a day, decoct twice in water, and take it 4--6 times after mixing[@bib104]Sanyeqing Power*T. hemsleyanum*Treatment of blood avalanche, leucorrheaOral administration[@bib25]Zhonggan mixture*T. hemsleyanum*, *Lysimachia christinae Hance*, *Imperata cylindrica*, *Citrus reticulata Blanco*Treatment of liver cancerOral administration, 30 mL once, 3 times a day[@bib38]Jinqi Tablet*T. hemsleyanum*, ginsenoside, *Astragalus propinquus* SchischkinTreatment of malignant tumorOral administration, 2 capsules once, 3 times a day[@bib90]Hua Shi Xuan Fei mixture*T. hemsleyanum*, *Nepeta cataria* L, *Lonicera japonica* Thunb, *Saposhnikovia divaricata* (Trucz.) SchischkTreatment of Covid-19Oral administration, 125 mL once, 2 times a dayZhejiang Provincial Drug AdministrationTable 2Chemical constituents isolated from the different parts of *T. hemsleyanum*.Table 2NameDetection ModeAnalysis parts of sampleReference**Flavonoids and their glycosides**quercetin **(1)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib77]quercitrin **(2)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib121]quercetin-3-O-glucoside **(3)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib77]quercetin-3-O-rutinoside **(4)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib76]quercetin-3-galactoside **(5)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]quercetin-3-O-xylosylglucoside **(6)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]quercetin-3-O-xylosylglucose-7-O-rhamnoside **(7)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]orientin **(8)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]orientin-2″-O-rhamnoside **(9)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]Isoorientin **(10)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77], [@bib76]isoorientin-2″-O-rhamnoside **(11)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]isoorientin −4″-O-xyloside **(12)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]vitexin **(13)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77], [@bib76]vitexin-2″-O-rhamnoside **(14)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77], [@bib76]vitexin-2″-O-glucoside **(15)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77], [@bib76]vitexin-2″-O-arabinoside **(16)**UPLC-ESI-QTOF-MS/MSaerial part[@bib76]isovitexin **(17)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77], [@bib76]isovitexin-2″-O-rhamnoside **(18)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]isovitexin-2″-O-xyloside **(19)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]isorhamnetin **(20)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]isorhamnetin-3-rutinoside **(21)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]isorhamnetin-3-pyranoarabinose-7-glucosylrhamnoside **(22)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]apigenin **(23)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib77]apigenin-7-rhamnoside **(24)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]apigenin-8-C-xylosyl-6-C-glucoside **(25)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]apigenin-6-C-α-L-arabinose-8-C-β-D-glucose **(26)**UPLC-ESI-QTOF-MS/MSaerial part[@bib76]eriodictyol **(27)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]eriodictyol-O-hexoside I **(28)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]eriodictyol-O-hexoside II **(29)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]luteolin **(30)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]luteolin-6, 8-di-C-hexoside **(31)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]catechin **(32)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77], [@bib76]catechin glucopyranoside isomer **(33)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]epicatechin **(34)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77], [@bib76]kaempferide **(35)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]kaempferol **(36)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77], [@bib76]kaempferol-3-glucoside **(37)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77], [@bib76]kaempferol-3-rutinoside **(38)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77], [@bib76]kaempferol-3-sambubioside **(39)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77], [@bib76]kaempferol-3-O-neohesperidin **(40)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib106]kaempferol-3-O-rhamnoside **(41)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib121]kaempferol-7-O-rhamnose-3-O-glucoside **(42)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib121]kaempferol-3-robinoside-7-rhamnoside **(43)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]kaempferol-3-rutinoside **(44)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]kaempferol-3-O-carfuran-7-O-rhamnosyl glucoside **(45)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]daidzein **(46)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]biochanin A **(47)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]procyanidin dimmer **(48)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]procyanidin B1 **(49)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib106]procyanidin B2 **(50)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib106]procyanidin trimer **(51)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib121]**Phenolic acids and derivatives**gallic acid **(52)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib77], [@bib106]protocatechuic acid **(53)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib77]caffeic acid **(54)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77], [@bib76]dihydroxybenzoic acid hexoside **(55)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]1-caffeoylquinic acid **(56)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]3-caffeoylquinic acid **(57)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]4-caffeoylquinic acid **(58)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]5-caffeoylquinic acid **(59)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]1-*p*-coumaroylquinic acid **(60)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]4-*p*-coumaroylquinic acid **(61)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]5-*p*-coumaroylquinic acid **(62)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib77]*p*-hydroxybenzaldehyde **(63)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]*p*-coumaric acid **(64)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]ferulic acid hexoside **(65)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]salicylic acid **(66)**UPLC-ESI-QTOF-MS/MS\
^1^H-NMR,^13^C-NMR, MSaerial part, root tuber[@bib77], [@bib24]chlorogenic acid **(67)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77], [@bib76]neochlorogenic acid **(68)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib106], [@bib18]cryptochlorogenic acid **(69)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib106], [@bib18]protocatechualdehyde **(70)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]salicin-2-benzoate **(71)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]trihydroxycinnamoylquinic acid isomer **(72)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]protocatechuic acid hexoside **(73)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]apiosylglucosyl 4-hydroxybenzoate **(74)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]1-*O*-galloyl-*β*-D-glucose **(75)**UPLC-ESI-QTOF-MS/MSaerial part[@bib76]protocatechol glucoside **(76)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib121]epigallocatechin **(77)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib76], [@bib106]vanillic acid-1-*O*-furan celery glucosyl ester **(78)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]protocatechuic acid-1-*O*-furan celery glucosyl ester **(79)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]methoxyphenol-1-*O*-furan glycosyl-*O*-glucoside **(80)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]2-methoxy-4-methylbenzene-1-o-furacresyl glucoside **(81)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib121]oxyresveratrol **(82)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib106]dicaffeoylquinic acid **(83)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib106]4*-*hydroxycinnamic acid **(84)**^1^H-NMR, LC-MSroot tuber[@bib2]**Alkaloids**indole **(85)**NMR, UV, MSaerial parts[@bib23]indole-3-carboxylic acid **(86)**NMR, UV, MSaerial parts[@bib23]indole-3-propanoic acid **(87)**NMR, UV, MSaerial parts[@bib23]5-hydroxy-indole-3-carboxaldehyde **(88)**NMR, UV, MSaerial parts[@bib23]5-hydroxyindole-3-carboxylic acid **(89)**NMR, UV, MSaerial parts[@bib23]6-hydroxy-3, 4-dihydro-1-oxo-β-carboline **(90)**NMR, UV, MSaerial parts[@bib23]hippophamide **(91)**NMR, UV, MSaerial parts[@bib23]4-hydroxycinnamide **(92)**NMR, UV, MSaerial parts[@bib23]pyrrole-3-propanoic acid **(93)**NMR, UV, MSaerial parts[@bib23]S-(−)-trolline **(94)**NMR, UV, MSaerial parts[@bib23]**Fatty acids**trihydroxy octadecadienoic acid **(95)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]trihydroxy octadecenoic acid **(96)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]dihydroxy octadecenoic acid **(97)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]9-hydroxy-10,12-octadecadienoic acid **(98)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]9-hydroxy octadecatrienoic acid **(99)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]hydroxy-octadecenoic acid **(100)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]hydroxy-octadecatrienoic acid **(101)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]Dihydroxy-octadecatrienoic acid **(102)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]dihydroartemisinin ethyl ether **(103)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]Trihydroxy octadecadienoic acid isomer **(104)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]hydroxy-oxo-octadecatrienoic acid **(105)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]octadecenedioic acid di-Me-ester **(106)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]stearic acid **(107)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]linolenic acid **(108)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]linoleic acid **(109)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]palmitic acid **(110)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]oleic acid **(111)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]**Organic acids and derivatives**malic acid **(112)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]quinic acid **(113)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]citric acid **(114)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77], [@bib76]azelaic acid **(115)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]oxalic acid **(116)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]galactonic acid **(117)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]gallic acid **(118)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]succinic acid **(119)**UPLC-ESI-QTOF-MS/MSaerial part, root tuber[@bib77], [@bib76]fumaric acid **(120)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]propanoic acid **(121)**GC-MSroot tuber[@bib76]**Terpenoids and steroids**β-sitosterol **(122)**TCLroot tuber[@bib2]daucosterol **(123)**H-NMR, C-NMR, MSroot tuber[@bib13]campesterol **(124)**GC-MSroot tuber[@bib76]Stigmasterol **(125)**GC-MSroot tuber[@bib76]6-*O*-benzoyl daucosterol **(126)**IR, H-NMR, EI-MSroot tuber[@bib27]ergosterol **(127)**IR, H-NMR, MSaerial part[@bib70]taraxerone **(128)**IR, H-NMR, MSaerial part[@bib70]Taraxerol **(129)**IR, H-NMR, MSaerial part[@bib70]α-amyrine **(130)**IR, EI-MSaerial part[@bib72]pteroside Z **(131)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]ganoderic acid H **(132)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]3-epipapyriferic acid **(133)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]oleanic acid **(134)**H-NMR, C-NMR, MSroot tuber[@bib13]**Saponins**Ginsenoside Rh~1~**(135)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]Ginsenoside Rh~2~**(136)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]Vinaginsenoside R~1~**(137)**UPLC-ESI-QTOF-MS/MSroot tuber[@bib77]**Amino acid and derivatives**Phenylalanine **(138)**UPLC-ESI-QTOF-MS/MSroot tuber, aerial part[@bib77]pyroglutamic acid **(139)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]glutimic acid hexose **(140)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]Tryptophan **(141)**UPLC-ESI-QTOF-MS/MSaerial part[@bib77]*L*-glutamic acid **(142)**UPLC-ESI-QTOF-MS/MSaerial part[@bib76]

5.1. Flavonoids and their glycosides {#sec5.1}
------------------------------------

Modern phytochemical studies have indicated that flavonoids are the representative and predominated class of constituents isolated from *T. hemsleyanum* ([@bib50]; [@bib128]) ([Table 2](#tbl2){ref-type="table"}). To date, fifty-one flavonoids and their glycosides have been extracted and identified from *T. hemsleyanum*. In this series compounds, quercetin (1), orientin (8), vitexin (13), isorhamnetin (20), apigenin (23) and kaempferol (36) are the main types of skeleton, some of their analogues can be identified from hydroxy moiety on C3′ and C4' on the B ring of flavonoid aglycone. At present, many modern analytical techniques have been used for qualitative and quantitative analysis of flavonoids. Among them, ultra high performance liquid chromatography tandem triple quadrupole time of flight mass spectrometry (UPLC-ESI-Q-TOF-MS) has become a powerful tool for identifying the complicated compounds due to its higher mass accuracy and resolution. Our team used UPLC-ESI-Q-TOF-MS to identify 31 chemical constituents from the aerial part of *T. hemsleyanum*, including 22 flavonoids, such as isoorientin (10), quercetin (1), kaempferol (36), vitexin (13), isovitexin (17), kaempferol-3-glucoside (37), etc ([@bib76]). According to the report ([@bib55]), total flavonoids of *T. hemsleyanum* could protect the aged mice from acute lung injury through inhibiting the phosphorylation of mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) in lung tissue. Moreover, the flavonoids of *T. hemsleyanum* had the activity of anti-lung cancer ([@bib91]). Luteolin (30), a flavonoid found in *T. hemsleyanum*, acted as an anticancer agent against various types of human malignancies such as lung, breast, glioblastoma, prostate, colon, and pancreatic cancers ([@bib59]). It is certain that *T. hemsleyanum* flavonoids give a new vision for researchers to explore clinical anticancer drugs.

5.2. Polysaccharide {#sec5.2}
-------------------

Saccharide is another important active ingredient extracted from *T. hemsleyanum* ([@bib75]). Polysaccharide has great potential in clinical application because of its unique pharmacological activity. However, due to the complex structure of polysaccharide, it is difficult and special to determine and synthesize their structures. [@bib27] extracted the polysaccharides from roots of *T. hemsleyanum*, RTP-1, RTP-2 and RTP-3 were successively found by protein precipitation and purification. Moreover, further study indicated RTP-3-1 was high purity polysaccharide with a molecular weight of 1244.2 kDa, and it is mainly composed of 4 kinds of monosaccharides: arabinose, galacturonic acid, galactose, and fructose, the proportion is 8.39%, 7.18%, 20.70%, and 63.70%, respectively. [@bib72], [@bib73]) extracted a polysaccharide THP from *T. hemsleyanum*, with the average molecular weight estimated as 93.307 kDa. The results of study on the composition of polysaccharide showed that it was mainly composed of rhamnose, arabinose, mannose, glucose, galactose with the molar ratio of 0.07:0.14:0.38:0.21:0.31. In 2019, [@bib70], [@bib71]) successfully extracted polysaccharide THDP-3 from *T. hemsleyanum* with molecular weight of 77.98 kDa, which consists of rhamnose, arabinose, mannose, glucose and galactose with molar ratio of 1.0: 1.3: 2.5: 2.3: 3.1. Moreover, TDGP-3 mainly consists of →4)-α-D-GalAp-(1→, →4)-β-D-Galp-(1→ and →4)-α-D-Glcp-(1→, residues as backbones and β-D-Manp-(1→, →3,6-β-D-Manp-1→ and α-D-Araf-(1→residues as branches.

5.3. Phenolic acids {#sec5.3}
-------------------

Phenolic acids refer to aromatic carboxylic acids with multiple phenolic groups substituted on one benzene ring. As a secondary metabolite, phenolic acids are widely found in many natural plants and have anti-inflammatory, antioxidant and lipid lowering effects. Twenty-three phenolic acids (No.52--84, [Table 1](#tbl1){ref-type="table"}) have been reported in the aerial parts of *T. hemsleyanum*, such as caffeic acid (54), chlorogenic acid (67), 1-*O*-galloyl-β-D-glucose (75), protocatechol glucoside (76), epigallocatechin (77), 1-caffeoylquinic acid (56), 3-caffeoylquinic acid (57), 4-caffeoylquinic acid (58), 5-caffeoylquinic acid (59), 1-*p*-coumaroylquinic acid (60), 4-*p*-coumaroylquinic acid (61) and 5-*p*-coumaroylquinic acid (62). There were twenty-one phenolic acids in the root tuber of *T. hemsleyanum*, some of which were the same as aerial parts.

5.4. Alkaloids {#sec5.4}
--------------

Alkaloids are a group of basic organic compounds containing nitrogen that exist in nature. Alkaloids are stored in small quantities in *T. hemsleyanum*, and the bioactivity investigations of those alkaloids are still rather rare. Wang ([@bib23]) extracted the aerial parts of *T. hemsleyanum* with 90% ethanol, and then isolated ten alkaloids for the first time, including seven indole alkaloids, an amide, a maleimide, and a carboline. By comparing with the spectral data of known compounds, the alkaloids were respectively identified as indole (85), indole-3-carboxylic acid (86), indole-3-propanoic acid (87), 5-hydroxy-indole-3-carboxaldehyde (88), 5-hydroxyindole-3-carboxylic acid (89), 6-hydroxy-3, 4-dihydro-1-oxo-β-carboline (90), hippophamide (91), 4-hydroxycinnamide (92), pyrrole-3-propanoic acid (93) and S-(−)-trolline (94). The chemical structures were shown in [Fig. 2](#fig2){ref-type="fig"} .Fig. 2Selected structures of chemical constituents isolated from *T. hemsleyanum*.Fig. 2

5.5. Organic acids and derivatives {#sec5.5}
----------------------------------

The biologically essential organic acids have been isolated and characterized from *T. hemsleyanum* as well. Ten organic acids and seventeen fatty acids were identified from the aerial parts and root tuber of *T. hemsleyanum*, most of which were found in the aerial parts, except stearic acid (97), propanoic acid (121) and dihydroxy octadecenoic acid (102). All the organic acids and fatty acids are listed in No.112--121 and No.95--111 of [Table 1](#tbl1){ref-type="table"}, respectively.

5.6. Terpenoids and steroids {#sec5.6}
----------------------------

Terpenoids and steroids are other kinds of secondary metabolites of *T. hemsleyanum*, thirteen of these compounds have been isolated and identified (NO.122--134, [Table 1](#tbl1){ref-type="table"}). Liu ([@bib110]; [@bib54]) isolated and identified α-amyrine (130), β-sitosterol (122), ergosterol (127), taraxerone (128), taraxerol (129) from the aerial part of *T. hemsleyanum*. In addition, daucosterol (123), campesterol (124), stigmasterol (125), 6-*O*-benzoyl-daucosterol (126), pteroside Z (131), ganoderic acid H (132), 3-epipapyriferic acid (133) and oleanic acid (134) were successively separated from the tuber roots of *T. hemsleyanum* ([@bib52]).

5.7. Inorganic elements {#sec5.7}
-----------------------

The mineral elements of TCM are indispensable supplements to the bioactive components, which are closely related to the efficacy, toxicity and side effects of TCM. Wu ([@bib92]) demonstrated that *T. hemsleyanum* contained twenty-seven different mineral elements, namely Li, Be, Na, Mg, Al, K, Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, As, Se, Rb, Ag, Cd, Cs, Ba, Hg, Ti, Pb, U. Moreover, Ca, Cu, Ni, Ba, Al, K have higher loading values, which are the characteristic elements of *T. hemsleyanum*. Wang ([@bib86]) has indicated that the contents of Fe, Mn, Zn and Cu in three populations of *T. hemsleyanum* cultivated in different environments were 323.1--346.6, 36.3--38.1, 23.0--25.1, 3.8--4.1 mg kg^−1^, respectively.

5.8. Other compounds {#sec5.8}
--------------------

In addition to the seven kinds of compounds mentioned above, amino acids derivatives in *T. hemsleyanum* are also reported, such as phenylalanine, pyroglutamic acid, glutimic acid hexose, tryptophan, L-glutamic acid.

6. Pharmacology {#sec6}
===============

The ethnomedical uses of *T. hemsleyanum* have stimulated various pharmacological studies on it. The extracts and isolated compounds from *T. hemsleyanum* showed a variety of bioactivities, such as antiviral, antibacterial anti-oxidant, antipyretic, analgesic, hepatoprotective, immunoregulatory, and antitumor activity. The detailed pharmacological activities of *T. hemsleyanum* were presented in [Table 3](#tbl3){ref-type="table"} and summarized as follows.Table 3Pharmacological effects of *T. hemsleyanum*.Table 3Crude drug/compoundsModel methodDose range/concentrationResultsreferences**Antiviral Activity**A, F, S~1~, S~2~Mice and CEF infected with HVJ, influenza virus PR6, VSV0.1--25 g/kg (i.g. for 114 days) *in vivo*, 0.125--1 mg/mL *in vitro*Cell proliferation↓, plaque formation↓, animal mortality↓[@bib111]quercetin (1), quercitrin (2), epicatechin (34), quercetin-3-O-rutinoside (4), kaempferol (36), kaempferol-3-glucoside (37), kaempferol-3-rutinoside (38), procyanidin dimmer (48)MDCK cells inoculated with influenza virus PR8-NS1-Gluc12.5--100 μg/mLIC~50~: 27.4 μg/mL, no cytotoxicity was observed at a concentration of as high as 200 μg/mL[@bib11]Ethyl acetate extracts of *T. hemsleyanum*HepG~2~ cellsIC~50~: 1.3--48.6 mg/L, CC~50~: 385.0 ± 56.9 mg/L[@bib114]BAF, EAFMA104 cellsTC~50~ and EC~50~ of BAF: 2^−3^ and 2^−10^, respectively, TC~50~ and EC~50~ of EAF: 2^−5^ and 2^−11^, respectivelyTI value of BAF: 128, TI value of EAF: 64Yang, Gao and Yan (2019)PEFHIV-1~ⅢB~ cellsCC~50~: 92.54 μg/mLEC~50~: 3.54--78.56 μg/mL, TI: 2.03--43.18[@bib16]**Antibacterial Activity**EAF, CFF*E. coli*, *S. typhi*, *K. pneumonia, P. citrinum*, *A. flavus*, *A. niger, R. nigricans*MIC of EAF: 125--250 μg/mL, MIC of CFF: 31.3--125 μg/mLInhibitory diameter zone \>10 mm[@bib98]*T. hemsleyanum* 's polysaccharide*E. coli*Inhibiting *E. coli*\'s growth through suppressing the F6P\'s secondary phosphorylation[@bib6]**Antioxidant Activity**Total phenolic acid of *T. hemsleyanum*DPPH assay, ABTS Assay, FRAP Assay8.28--38.47 mg/gDPPH, 3.32 mmol of Trolox/g DW; ABTS, 1.38 mmol of Trolox/g DW; FRAP, 1.85 mmol of FeSO~4~/g DW[@bib79]Quercetin (1), quercetin-3-O-glucoside (3), procyanidin B1 (49), procyanidin B2 (50), protocatechualdehyde (70), epigallocatechin (77)DPPH assayIC~50~: 12.4--15.99 μmol/LTheir antioxidant activities were better than that of vitamin C[@bib24]Methanol extracts of *T. hemsleyanum* leafSD rats intraperitoneally injected with D-galactose solution200--1000 mg/kgSOD↑, GSH↑, MDA↓, T-AOC↑[@bib81]A polysaccharide TDGP-3 from *T. hemsleyanum*ICR mice received a high-fat diet for 35 consecutive days100--300 mg/kgSOD↑, GSH-Px↑, CAT, MDA↓[@bib8]Ethanol extract of *T. hemsleyanum*DPPH assay, FRAP Assay, Prieto method20--1000 μg/mLThe antioxidant capacity was associated with the contents of total flavonoids and total phenolics[@bib103]Total flavonoids of *T. hemsleyanum* root tuberDPPH assay, ABTS Assay, FRAP AssayDPPH, 27.4 μmol of Trolox/g DW; ABTS, 35.1 μmol of Trolox/g DW; FRAP, 43.3 μmol of Trolox/g DW[@bib115]Total flavonoids and phenolic acid of *T. hemsleyanum* leafDPPH assay6.25--100 mg/kgThe antioxidant capacity was associated with the contents of total phenolics[@bib30]**Antipyretic and Analgesic Activity**Ethanol extract of *T. hemsleyanum*Rats induced with Brewer\'s yeast or 2, 4-dinitrophenol1.2--4.8 g/kgBody temperature↓, and the duration was up to 180 min[@bib35]Aqueous extract of *T. hemsleyanum*Wiser rats induced with Brewer\'s yeast2--6 g/kg5-HT↓, NE↓, DA↓[@bib113]A polysaccharide from *T. hemsleyanum* aerial partKunming mice induced with Brewer\'s yeast200, 400 mg/kgBody temperature↓[@bib135]Ethanol extract of *T. hemsleyanum*Mice induced with acetic acid and hot plate test1.2--4.8 g/kgThe pain threshold↑, times of twisting body↓[@bib35]Ethanol extract of *T. hemsleyanum*Mice induced with acetic acid2.5 g/kgTimes of twisting body↓, the pain threshold↑[@bib87]Aqueous extract of *T. hemsleyanum*Mice induced with diethylstilbestrol and oxytocin1.25--5.0 g/kgTimes of twisting body↓, the pain threshold↑, the tension of smooth muscle↓[@bib57]Ethanol extract of *T. hemsleyanum*Kunming mice induced with acetic acid and hot plate test30--120 mg/kgThe pain threshold↑, times of twisting body↓, the maximum of analgesic ratio was 65.58%[@bib47]**Anti-inflammatory Activity**Ethanol extract of *T. hemsleyanum*Xylene-induced ear edema in mice2.5 g/kgDegree of swelling↓, the inhibition rates↑[@bib87]Ethanol extract of *T. hemsleyanum*Xylene-induced ear edema in mice, carrageenan-induced paw edema of acute inflammation in rats30--120 mg/kg (i.g. for 3 days or 7 days)The inhibition rates↑[@bib47]Ethanol extract of *T. hemsleyanum*Xylene-induced ear edema in mice, albumin-induced paw edema in rats1.2--4.8 g/kg (i.g. for 4 days)Degree of swelling↓, the inhibition rates↑[@bib35]A purified polysaccharide from *T. hemsleyanum*RAW264.7 cells induced by LPS12.5--50 μg/mLCOX-2↓, iNOS↓[@bib8]Total flavonoids of *T. hemsleyanum*C57BL/6 J mice induced by LPS40--80 μg/g (i.g. for 3 days)TNF-α↓, IL-1β↓, IL-6↓, IL-12p40↓, sTNF-R1↓, IL-10↑[@bib55]Total flavonoids of *T. hemsleyanum*RAW264.7 cells induced by LPS10--160 μg/mLTNF-α↓, IL-1β↓, IL-6↓, IL-12p40↓, sTNF-R1↓, IL-10↑, iNOS↓, NF-κB↓, phosphorylation of JNK↓[@bib53]Aqueous extract of *T. hemsleyanum*COPD model rats were induced by exposure to cigarette smoke and endotracheal instillation of LPS1.0 g/kg (i.g. for 28 days)IL-23↓, IL-17↓[@bib88]Polysaccharide from *T. hemsleyanum*RAW264.7 cells induced by LPS25--100 μg/mLTNF-α↓, IL-6↓[@bib33]Total flavonoids of *T. hemsleyanum*Balb/c mice induced by Con A1--4 g/kg (i.g. for 28 days)IL-17↓, IL-6↓, TGF-β1↑, IL-10↑, Foxp3↑, RORγt↓,[@bib37]**Hepatoprotective Activity**Aqueous extract of *T. hemsleyanum*SD rats induced by CCl~4~1.6 g/kg, 16 g/kg (i.g. for 6 days)GOT↓, ALP↓, MDA↓, SOD↑, GPT↓[@bib95]Aqueous extract of *T. hemsleyanum*Kunming mice induced by CCl~4~0.6--2.4 g/kg (i.g. for 7 days)ALT↓, AST↓, MDA↓, SOD↑[@bib133]Total amino acids from *T. hemsleyanum*Kunming mice induced by CCl~4~250, 500 mg/kg (i.g. for 7 days)ALT↓, AST↓, liver index↓, MDA↓, SOD↑[@bib34]Ethanol extract of *T. hemsleyanum*Kunming mice induced by α-isothiocyanate1.0--4.0 g/kg (i.g. for 10 days)ALT↓, AST↓, MDA↓, SOD↑, TNF-α↓,[@bib45]Aqueous extract of *T. hemsleyanum*SD rats induced by CCl~4~1.0--4.0 g/kg (i.g. for 8 weeks)ALT↓, AST↓, HA↓, LN↓, T-BiLi↓, TP↓[@bib127]Aqueous extract of *T. hemsleyanum*Kunming mice induced by calmette-Guerin bacillus vaccine and LPS20--40 g/kg (i.g. for 10 days)MDA↓, SOD↑, ALT↓, AST↓, LDH↓[@bib112]Polysaccharide from *T. hemsleyanum*ICR mice induced by CCl~4~0.125, 0.2 mg/g (i.g. for 7 days)ALT↓, AST↓, MDA↓, SOD↑[@bib58]**Immunoregulatory Activity**Ethyl acetate extract of *T. hemsleyanum*ICR mice induced by Con A2.5--25 g/kg (i.g. for 15 days)IFN-γ↑, TNF-α↑[@bib12]Aqueous extract of *T. hemsleyanum*Back of SD rats were immersed in 100 °C water for 12s1.2--4.8 g/kg (i.g. for 7 days)IgA↑, S-IgA↑, MDA↓, IL-6↓[@bib133]*T. hemsleyanum* powerSanhuang Broiler mixed feeding with 0.5%, 1% and 2% of *T. hemsleyanum* power diet for 20 daysIL-1↑, IL-4↑, the index of immune organs↑, TNF-γ↑, TNF-α↑[@bib4]Ethyl acetate extract of *T. hemsleyanum*ICR mice induced by Con A9.1--91.2 mg/kg (i.g. for 15 or 30 days)IFN-γ↑, TNF-α↑, the proliferation of T and B↑,[@bib100]

6.1. Antiviral activity {#sec6.1}
-----------------------

According to Yang\'s literatures ([@bib111]), the nitrogenous alkali-containing extract (A), ketone-containing extract (F), crude extract (S~1~), and crude extract (S~2~) of *T. hemsleyanum* had different antiviral effect on mice and chicken embryo fibroblast (CEF) infected with Hemagglutinating virus of Japan (HVJ), influenza virus PR6, vesicular stomatitis virus (VSV). Specifically, S~2~ strongly inhibited the proliferation of influenza virus PR6 with at the concentration of 0.5 mg/mL, and 0.5 mg/mL S~1~ has obvious antiviral effect on HVJ. At the concentrations of 10 mg/mL and 1 mg/mL, both F and S1 displayed a strong suppressive effect on the plaque formation of VSV. *In vivo*, A, F, S~1~, S~2~ have different degrees of antiviral activity. When the concentration of A was 0.1 g/kg, the protective rate was up to 50%, and that of S~1~ (0.2 g/kg) was 20%. However, the author did not give the sample preparation method. [@bib11] had demonstrated compounds quercetin-3-O-rutinoside (4), kaempferol (36), kaempferol-3-glucoside (37), quercitrin (2), quercetin (1), kaempferol-3-O-rutinoside (38), procyanidin dimmer (48), and epicatechin (34), which were isolated from *T. hemsleyanum*, were positively related to the activity of *T. hemsleyanum* against H1N1 influenza virus. The ethyl acetate extracts of *T. hemsleyanum* have been shown to obviously restrain the secretion of HbsAg and HbeAg released by HBV, with the IC~50~ values of 1.3--48.6 mg/L. However, the specific mechanism of action needs to be further confirmed ([@bib114]). Wang had proved that the n-butanol and ethyl acetate extraction of *T. hemsleyanum* had antiviral activity against RSV and were superior to ribavirin with the EC~50~ values of 0.008 mg/L ([@bib83]). Moreover, the *T. hemsleyanum* extracts had different degrees of inhibition to different HIV-1 strains. The EC~50~ values were between 3.54 μg/mL and 78.56 μg/mL and the therapeutic index values were between 2.03 and 43.18. The EC50 values of *T. hemsleyanum* extract for blocking the fusion of HIV-1 chronic infected cells and normal lymphocytes C8166 cells was 14.79 μg/mL and the EC50 for inhibiting the recombinant HIV-1 reverse transcriptase was 170.15 μg/mL ([@bib16]). Although these studies have demonstrated that *T. hemsleyanum* could be used in the treatment of different viruses, the mechanism has been barely reported.

6.2. Antibacterial activity {#sec6.2}
---------------------------

*T. hemsleyanum* was used in the treatment of throat swelling and pain, sore and toxin, pneumonia and fever, and these diseases were mostly relevant to the invasion of microorganisms. [@bib98] used *S. aureus* LMA1213 and *B. subtilis* LMA0106, *E. coli* LMA 1226, *S. typhi* LMA0217, *K. pneumonia* LMA0725, *M. racemosus* LMA3221, *P. citrinum* LMA7126, *A. flavus* LMA0816, *A. niger* LMA3601, *R. nigricans* LMA2429 as tested species, and evaluated the inhibitory diameter, minimum inhibitory concentration (MIC) of *T. hemsleyanum* ethanol extracts using oxford cup method and broth micro-dilution method. The results indicated that *T. hemsleyanum* showed the strongest activity against *S. aureus* and *B. cereus*, MIC value both were 62.5 μg/mL. Ethyl acetate extract of *T. hemsleyanum* ethanol extract (EAF) exhibited the strongest inhibitory activity on *E. coli*, *S. typhi* and *K. pneumonia*. MIC value ranges from 125 μg/mL to 250 μg/mL. Meanwhile, chloroform extract of *T. hemsleyanum* ethanol extract (CFF) exhibited remarkable activity against *P. citrinum*, *A. flavus*, *A. niger* and *R. nigricans*. MIC value ranges from 31.3 μg/mL to 125 μg/mL. Chen ([@bib6]) had clarified the antibacterial mechanism of *T. hemsleyanum*\'s polysaccharide was that it could inhibit the proliferation of *E. coli* by interfering with glycolysis and gluconeogenesis.

6.3. Antioxidant activity {#sec6.3}
-------------------------

Antioxidant activity is a prominent value for the further development of natural products. According to the study ([@bib79]), 80% methanol extract of *T. hemsleyanum* leaves exhibited the highest DPPH radical scavenging activity, with the value of 3.32 mmol of Trolox/g DW, and a similar result was also found in the ABTS radical scavenging activity experiment (1.38 mmol of Trolox/g DW). In the ferric reducing activity assay, 80% methanol extract of *T. hemsleyanum* leaves had the highest value (1.85 mmol of FeSO~4~/g DW). Moreover, the results of relationship between phenolic content and antioxidant activity suggested that the phenolics of *T. hemsleyanum* leaves extracts were the main contributors to the antioxidant activities. In Fu\'s research ([@bib24]), it had been found that the antioxidant activities of quercetin (1), epigallocatechin (77), procyanidin B1 (49), procyanidin B2 (50), protocatechualdehyde (70) and quercetin-3-O-glucoside (3) in *T. hemsleyanum* were better than those of vitamin C, and the antioxidant capacity was correlated with the amount of total flavonoids and total polyphenols. It was also confirmed by literature ([@bib103]; [@bib115]), which suggested that total flavonoids and total phenols might be the material basis of antioxidant activity. Sun ([@bib81]) established an oxidative stress rat model by D-galactose, total antioxidant capacity, superoxide dismutase (SOD), glutathione (GSH) peroxidase activities of rats were increased after treatment of *T. hemsleyanum*. Meanwhile, the content of GSH was increased and malondialdehyde (MDA) content was decreased in plasma and tissues of these rats. Interestingly, Chu ([@bib8], [@bib9]) isolated a purified polysaccharide from *T. hemsleyanum*, the results of pharmacological experiment showed that it could ameliorate oxidative damage in RAW264.7 cells via Nrf2-Keap1 and Sirt1-FoxO1 pathways. Based on the above findings, the antioxidant activity of *T. hemsleyanum* has the characteristics of multi-components, multi-targets and multi-pathways.

6.4. Antipyretic and analgesic activity {#sec6.4}
---------------------------------------

In the folk, *T. hemsleyanum* is widely used in the treatment of infantile hyperpyretic convulsion, which was also confirmed by Brewer\'s yeast or 2, 4-dinitrophenol induced hyperthermia test of rats ([@bib35]). More specifically, the temperature of rats treated with *T. hemsleyanum* extracts remarkably fell and 5-hydroxytryptamine (5-HT), norepinephrine (NE), dopamine (DA) in hypothalamus also significantly decreased ([@bib113]). Besides, a purified polysaccharide from aerial parts of *T. hemsleyanum* with average molecular weight of 66.2 kDa could markedly suppress the levels of prostaglandin E2 (PGE2) in serum of mice ([@bib135]). The analgesic activity of *T. hemsleyanum* was investigated by acetic acid or oxytocin induced writhing response in mice and hot plate test, and the results manifested that *T. hemsleyanum* could reduce the number of abdominal writhing and increase the pain threshold in hot plate test in a dose-dependent manner ([@bib87]). *T. hemsleyanum* could reduce the tension of isolated mouse uterus and the writhing times of oxytocin-induced mice model ([@bib57]). The results further showed the aerial parts of *T. hemsleyanum* also had analgesic activity taken these finding into consideration as follow: increased the rate of pain threshold prolongation with the maximum extension of analgesic ratio of 65.58%, inhibited acetic acid-induced writhing pain in mice, prolonged the latency of mice\'s writhing and alleviated the writhing responses with the maximum inhibition ratio of 51.80% ([@bib47]). However, the bioactive compounds and the mechanism of action have not been reported in any literature.

6.5. Anti-inflammatory activity {#sec6.5}
-------------------------------

Inflammation has been reported to produce negative effect on various diseases. Consistent with traditional uses, *T. hemsleyanum* exerted anti-inflammatory activity, the regulation mechanism was closely related to the target molecules including NF-κB and MAPK ([@bib55]). A purified polysaccharide with the average molecular weights of 478.33 kDa from *T. hemsleyanum* could attenuate inflammation stimulated with lipopolysaccharide (LPS) through suppressing the phosphorylation of MAPKs, down-regulating the expression of COX-2 and iNOS in RAW264.7 cells. Moreover, the purified polysaccharide also improved the growing development and athletic ability of *Caenorhabditis elegans* (*C.elegans*), ameliorated the ability of scavenge ROS, O~2~ ^−^, recovered GSH against LPS-induced inflammation in *C. elegans* ([@bib8], [@bib9]). Liu ([@bib53]) discovered that *T. hemsleyanum* reduced the production of tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin 6 (IL-6), interleukin 12 subunit p40 (IL-12p40), soluble TNF receptors 1 (sTNF-R1) and increased anti-inflammatory cytokine interleukin 10 (IL-10) expression in LPS-induced RAW264.7 cells, which were consistent with the other studies ([@bib88]; [@bib33]). Meanwhile, *T. hemsleyanum* dose-dependently inhibited the production of inducible NO synthase (iNOS) and NO, attenuated the up-regulated expression of Toll-like receptor 4 (TLR4), myeloid differentiation factor-2 (MD-2), myeloid differentiation protein 88 (MyD88) and TLR4/MD-2 complex induced by LPS. Along with the change of TLR4/MD-2, the phosphorylation and activity of c-Jun N-terminal kinase (JNK) and NF-κB were changed at the same time. These data revealed *T. hemsleyanum* might contribute to the alleviation of LPS-induced inflammatory reaction in RAW264.7 cells via TLR4/MD-2 mediated NF-κB and JNK pathway. Besides, our previous research proved that total flavonoids from *T. hemsleyanum* (1, 2 and 4 g/kg) and a positive control drug bifendate (200 mg/kg) could ameliorate inflammatory response in autoimmune hepatitis mice by mediating Treg/Th17 immune homeostasis ([@bib37])*.*

6.6. Hepatoprotective activity {#sec6.6}
------------------------------

Previous findings have demonstrated that *T. hemsleyanum* has protective effects on various types of liver injury. Water decoction of *T. hemsleyanum* (1.6 g/mL and 0.16 g/mL) relieved liver injury caused by carbon tetrachloride (CCl~4~) through decreasing the contents of glutamic-pyruvic transaminase (GPT), glutamic-oxalacetic transaminase (GOT), alkaline phosphatase (ALP) and MDA, while increasing the activity of SOD ([@bib95]). Moreover, water extract and total amino acids of *T. hemsleyanum* could obviously reduce the activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), liver index and the content of MDA in liver, increase the activity of SOD in live, and the protective effect of *T. hemsleyanum* on liver injury was better than that of biphenyl diester. Furthermore, the pathologic changes of hepatic tissue demonstrated that they could reduce the degree of necrosis, degeneration of inflammatory cell, and infiltration of hepatocytes ([@bib133], [@bib134]; [@bib34]). Besides, *T. hemsleyanum* extract had a protective effect on liver injury induced by α-isothiocyanate in mice, which was relevant to the reduction of inflammatory factors, promotion of the total bilirubin metabolism and alleviation of the lipid peroxidation ([@bib45]). As for chronic liver injury, Zhang ([@bib127]) observed that the extract of *T. hemsleyanum* reduced the levels of ALT, AST, hyaluronan (HA), laminin (LN), and total bilirubin (T-BiLi), suppressed the content of total protein (TP) and albumin, improved the ratio of albumin/globulin and the survival rate of chronic hepatic damage rat administrated with CCl~4~ ([Fig. 3](#fig3){ref-type="fig"} ). With regard to the mice with immune liver injury induced by Calmette-Guerin bacillus vaccine and LPS, *T. hemsleyanum* (20, 30, 40 g/kg) could also regulate the change of above factors at different levels ([@bib112]). Unfortunately, the bioactive components of *T. hemsleyanum* against liver injury have not been reported so far.Fig. 3The protective effects of *T. hemsleyanum* on liver injury.Fig. 3

6.7. Immunoregulatory activity {#sec6.7}
------------------------------

It is believed that the ability of body to cope with diseases depends not only on the adaptive immune response of T and B lymphocytes to specific antigens, but also on the natural immune response. Once the immune system is out of order, the pathological changes of organ tissues will ensue. Xu ([@bib100]) had reported that the ethyl-acetate fraction of *T. hemsleyanum* enhanced the proliferation of T and B lymphocyte and antibody activity at the dose of 1.82 mg/mL, 5.48 mg/mL, and 9.12 mg/mL, affected delayed-type hypersensitivity and mononuclear-macrophage phagocytosis, and increased the production of serum interferon-gamma (IFN-γ) and serum TNF-α at the dose of 9.12 mg/mL, which was in accordance with Ding\'s findings ([@bib12]). The extract of *T. hemsleyanum* (1.2, 2.4, 4.8 g/kg) could antagonize the decrease of serum immunoglobulin A (IgA) content and secretory immunoglobulin A (S-IgA) content in ileum mucus, spleen lymphocyte proliferation, natural killer cell activity, the increase of MDA content in intestinal mucus and serum IL-6 level in scalded rats ([@bib133], [@bib134]). In addition, it has been reported that *T. hemsleyanum* could also increase the levels of IL-1, IL-4 and the index of immune organs ([Fig. 4](#fig4){ref-type="fig"} ) ([@bib4]). Due to the complex constituents of the extract, the immunomodulatory mechanism of *T. hemsleyanum* need to be further studied.Fig. 4*T. hemsleyanum* enhanced the differentiation of T cell, reduced inflammatory response, improved cell immunity and alleviated cell damage.Fig. 4

6.8. Antitumor activity {#sec6.8}
-----------------------

In recent years, *T. hemsleyanum* has been widely used in the prevention and treatment of lung cancer, stomach cancer, colorectal cancer, liver cancer, breast cancer, cervical cancer, thyroid cancer, esophageal cancer, pancreatic cancer, lymphoid cancer and brain tumor ([@bib8], [@bib7]). It has the characteristics of multi-target, multi-pathway, synergistic effect, non-toxicity, which is valuable for the development of new drugs for the treatment of tumor. Although the mechanism has not been fully elucidated, its antitumor effect may be achieved by inhibiting tumor cell proliferation and migration, inducing cell apoptosis, enhancing immune function.

### 6.8.1. Inhibiting tumor cell proliferation and migration {#sec6.8.1}

The abnormal regulation of cell cycle is an important reason for tumorigenesis. CyclinD1 is a key regulatory protein in G1 phase, and the disorder of G1 phase would lead to the occurrence of tumor. Proto oncogene c-myc is a nuclear protein regulatory gene, Lgr5 is a stem cell marker, and both of them highly expressed in a variety of tumor. Epithelial-mesenchymal transition (EMT) is characterized by a loss of epithelial proteins including E-cadherin, and increased expression of vimentin. EMT is closely connected with the migration and invasion of malignant tumors which accompanied by change activity of matrix metalloproteinase (MMPs) and tissue inhibitor of matrix-metallo proteinase (TIMPs). According to the studies ([@bib96]; [@bib125], [@bib126]; [@bib62]; [@bib129]; [@bib131]; [@bib130]; [@bib118]; [@bib117]; [@bib89]; [@bib85]; [@bib39]; [@bib102]; [@bib101]; [@bib108], [@bib109]; [@bib108], [@bib109]), the active components of *T. hemsleyanum* on the one hand could suppress the expression of Lgr5, CyclinD1 and c-myc, block the cell cycle in G~0~/G~1~ phase, reduce the transformation of tumor cells from G~1~ phase to S phase and then intercept the cell cycle in S and G~2~/M phase, so that the mitosis process of tumor cells would be blocked and cell proliferation be inhibited ([Fig. 5](#fig5){ref-type="fig"} ). On the other hand, they could decrease the expression of E-cadherin, vimentin, MMP-2 and MMP-9, increase the expression of TIMP-2, suppress the activity of the Wnt/β-catenin pathway and Notch pathway, so that tumor migration and invasion would be inhibited.Fig. 5*T. hemsleyanum* blocked the mitosis process of tumor cells and inhibited the cell proliferation, invasion and metastasis.Fig. 5

### 6.8.2. Inducing apoptosis of tumor cells {#sec6.8.2}

Apoptosis is a cell suicide phenomenon that occurs in a specific time and space. It is closely regulated through a variety of cell signaling pathways, such as mitochondrial apoptotic pathway and death receptor apoptotic pathway. Bcl-2 protease family is the key protein in mitochondrial apoptosis pathway, which can be divided into two categories: pro apoptotic proteins such as Bax and bid and anti-apoptotic proteins such as bcl-2 ([Fig. 6](#fig6){ref-type="fig"} ). Cytochrome *c* (Cyt-c) and apoptosis inducing factor were released under the action of apoptotic signal. The combination of Cyt-c and apoptosis activator, such as caspase-8, caspase-9 and caspase-10 could activate the downstream apoptosis executor enzymes, such as caspase-3 and caspase-6, and that finally lead apoptosis. Besides, ROS can produce many kinds of free radicals, which cause cell stress reaction and trigger cell apoptosis. However, many types of antioxidant enzymes can scavenge excessive ROS, such as SOD, catalase (CAT) and glutathione peroxidase (GSH-Px). As shown in [Table 4](#tbl4){ref-type="table"} , *T. hemsleyanum* could reduce mitochondrial membrane potential, increase intracellular Ca^2+^ concentration, down-regulate the expression of Bcl-2 protein, promote the expression of Bax and Cyt-C protein in tumor cells, and thus activate mitochondrial apoptosis induction pathway. On the other hand, it could activate the expression of caspase protease family, thus induce apoptosis ([@bib66], [@bib67]; [@bib78]; [@bib5]; [@bib99]; [@bib63]; [@bib56]; [@bib42]; [@bib15]; [@bib49]; [@bib44]; [@bib84]; [@bib119]; [@bib120]; [@bib132]; [@bib125], [@bib126]; [@bib122]; [@bib94]). Furthermore, *T. hemsleyanum* could reduce the activity of SOD, CAT and GSH-Px, increase the level of MDA, and enhance the oxidative stress response of tumor cells, thus accelerate the occurrence of apoptosis ([@bib98]).Fig. 6The enhancement of mitochondrial membrane permeability, the destruction of mitochondrial integrity and the stimulation of ROS cause apoptosis of tumor cells.Fig. 6Table 4Mechanism of *T. hemsleyanum* in the treatment of tumor.Table 4Crude drug/CompoundMethods usedDose range/concentrationResultsReference**Inhibiting proliferation of tumor cell**quercetin-3-O-glucoside (**3**)NBT-II cells1--25 μg/mLHGF/SF-Met signaling↓, migration↓, invasion↓[@bib96]*T. hemsleyanum* FlavonesEC9706 cells0.5--20 g/LThe inhibition rate of cell↑, adhesion rate↓, migration rate↓, invasion cell number↓, Notch1 mRNA ↓[@bib125]*T. hemsleyanum* Flavonesmice inoculated H~22~ cells15--90 mg/kg (i.g. for 12 days)Cell growth↓, TIMP-2↑[@bib62]*T. hemsleyanum* FlavonesA549 cells0.5--10 g/LCell growth↓, apoptosis↑, p-p38↑, p-ERK↑[@bib132]*T. hemsleyanum* FlavonesA549 cells0.5--10 g/LCell proliferation↓, cell migration↓, MMP-2↓, MMP-9↓, TIMP-2↑[@bib131]*T. hemsleyanum* FlavonesA549 cells1--10 mg/mLCell proliferation↓, DUB activity↓, ub-prs↑, USP14↓, UCHL5↓, POH1↓[@bib130]*T. hemsleyanum* FlavonesHT29 and SW620 cells1.6--6.4 mg/mLThe proportion of S + G2/M phase, β-Catenin↓, Cyclin D1↓, c-myc↓[@bib118]*T. hemsleyanum* FlavonesAOM-DSS induced C57BL/6 mice4--8 g/kg (i.g. for 114 days)Tumor volume↓, Lgr5↓, Cyclin D1↓, c-myc↓, E-cadherin↓, Vimentin↓, Wnt/β-catenin pathway↓[@bib117]*T. hemsleyanum* FlavonesBALB/c mice inoculated HepG~2~ cells3.75--15 g/kg (i.g. for 21 days)Tumor growth↓[@bib89]Ethylacetate extract of *T. hemsleyanum*HepG~2~ cells5--25 g/kg (i.g. for 21 days)Tumor growth↓, IFN-γ↑, TNF-α↑[@bib85]Ethanol extract of *T. hemsleyanum*MCF-7 cells5--160 g/LCell proliferation↓, migration↓, proportion of cells in G~0~/G~1~ phase↓, apoptosis rate↑[@bib39]Ethanol extract of *T. hemsleyanum*HL60 cells1.56--6.25 μg/mLCell proliferation↓, apoptosis rate↑[@bib102]Ethanol extract of *T. hemsleyanum*K562 cells3.13--100 μg/mLCell growth↓, apoptosis rate↑, P53↑, C-myc↓[@bib101]Lyophilized powder of *T. hemsleyanum*C57BL/6 J mice inoculated H~22~ cells1.79--7.16 g/kgCell growth↓, prolong survival rate↑[@bib108]Lyophilized powder of *T. hemsleyanum*BALB/c mice inoculated A549 cells1.79--7.16 g/kgCell growth↓, tumor volume↓[@bib108]**Inducing apoptosis of tumor cells**Ethylacetate extract of *T. hemsleyanum*HepG~2~ cells0--200 μg/mLCa2^+^↑, cytochrome *c*↑, caspase-3↑, caspase-9↑[@bib66]Methanol extract of *T. hemsleyanum* leavesKun-Ming mice inoculated H~22~ cells250--500 mg/kg (i.g. for 16 days)Cell growth↓, Bcl-2↓, Bax↑, VEGF↓, cle-caspase 9↑, cle-caspase 9↑[@bib78]Ethylacetate extract of *T. hemsleyanum*HepG~2~ and SMMC-7721 cells50--250 μg/mLCell proliferation↓, Bcl-2↓, caspase-3↑, Bax ↑[@bib5]Ethanol extract of *T. hemsleyanum* root tuberHeLa cells10--40 μg/mLCell growth↓, caspase-3↑, caspase-9↑, caspase-8↑[@bib99]Ethylacetate extract of *T. hemsleyanum*HepG~2~ cells50--200 μg/mLThe proportion of Bcl~2~/Bax↓, p53↑, outflow of Ca2^+^↓, Cytochrome C↑, caspase-9↑, PARP↑, pro-caspase-3↑[@bib63]Ethylacetate extract of *T. hemsleyanum*HT-29 cells0.1--10 mg/LCyto C↑, Bax↓, Cytochrome C↑[@bib56]Ethylacetate extract of *T. hemsleyanum*C57BL/6 J mice inoculated Lewis lung cancer cells0.1--0.3 g/kg (i.g. for 14 days)Apoptosis rate↑, Bcl~2~↓, Bax↑, caspase-3↑[@bib42]Ethylacetate extract of *T. hemsleyanum*PANC-1 cells50--200 μg/mLBax↑, P53↑, Bcl~2~↓[@bib15]Ethylacetate extract of *T. hemsleyanum*Balb/c mice inoculated HT29 cells0.1--0.3 g/kg (i.g. for 14 days)Tumor weight↓, caspase-3↑[@bib49]Ethanol extract of *T. hemsleyanum*Hela cells1--16 mg/LThe inhibition rate of cell↑[@bib44]Ethylacetate extract of *T. hemsleyanum*HCCC-9810 cells25--200 μg/mLCell proliferation↓, caspase-3↑[@bib85]Ethanol extract of *T. hemsleyanum*A549 cells1--100 mg/LRate of apoptosis↑[@bib119]Ethanol extract of *T. hemsleyanum*A549 cells1--100 mg/LCaspase-3↑[@bib120]Ethylacetate extract of *T. hemsleyanum*H1299 cells0.5--10 mg/mLpro-caspase-3↓, cle-PARP↑, pro-caspase-9↓, PARP↓, cle-caspase-3↑, cle-caspase-9↑[@bib132]*T. hemsleyanum* FlavonesSPC-A-1 cells0.5--10 g/LCell proliferation↓, cleaved- caspase-3↑[@bib125]*T. hemsleyanum* FlavonesSMMC-7721 cells2--10 mg/mLCell proliferation↓, Rate of apoptosis↑[@bib122]*T. hemsleyanum* FlavonesSW620 cells0.25--1 mg/mLCell proliferation↓, cle-caspase-3↑, cle-caspase-9↑, Bax↑, Bcl~2~↓[@bib94]Petroleum Ether Fraction of *T. hemsleyanum*Hela cells10--40 μg/mLCaspase-3↑, caspase-8↑, caspase-9↑, CAT↓, SOD↓, GSH-pX↓, MDA↑[@bib98]**Enhancing immune function**Total flavonoids of *T. hemsleyanum*C57BL/6 mice inoculated lewis lung carcinoma cells5--15 mg/kg (p.o. for 14 days)Tumor growth↓, regulatory T-cell development↓, TGF-β↓, PGE2↓COX2↓[@bib19]*T. hemsleyanum* FlavonesC57BL/6 mice inoculated lewis lung carcinoma cells7.5--30 mg/kg (i.g. for 14 days)Tumor volume↓, TGF-β↓, PGE2↓, COX2↓[@bib19]*T. hemsleyanum* FlavonesC57BL/6 mice inoculated lewis lung carcinoma cells3.125--12.5 mg/kg (i.g. for 14 days)PGE2↓, COX2↓[@bib123]*T. hemsleyanum* FlavonesC57BL/6 mice inoculated Lewis lung cancer cells5--20 mg/kg (i.g. for 14 days)Arg-1↓, iNOS↓, MDSCs(GR-1^+^ CD11b^+^)↓, proportion of CD8^+^ T cells↓, CD4^+^T cells↑, ratio of CD4^+^T/CD8^+^T↑[@bib31]*T. hemsleyanum* FlavonesC57BL/6 mice inoculated Lewis lung cancer cells7.5--30 mg/kg (i.g. for 23 days)The proportion of Treg cell↓, CD152↓[@bib123]Ethylacetate extract of *T. hemsleyanum*C57BL/6 mice inoculated Lewis lung cancer cells5--25 g/kg (i.g. for 14 days)Tumor weight↓, spleen index↑, thymus index↑, IFN-γ↑, TNF-α↑[@bib43]Polysaccharide of *T. hemsleyanum* aerial partBALB/c mice inoculated with 4T1 cells50--250 mg/kg (i.g. for 14 days)Tumor volume↓, liver index↓, CD4^+^↓, CD25^+^↓, Foxp3^+^↓, Treg cells↓, the proportion of CD3^+^/CD4^+^↑, CD3^+^/CD8^+^ ↑, CD4^+^/CD8^+^ ↑[@bib26]*T. hemsleyanum* and its formula with ginseng or curcuma wenyujin615 mice inoculated MFC cells2.25--2.70 g/kg (i.g. for 22 days)Tumor volume↓, Treg ratio↓, COX-2↓, PGE2↓[@bib19]

### 6.8.3. Enhancing immune function {#sec6.8.3}

It has been well documented that the promotion of body immunity played a pivotal role in cancer development and treatment ([@bib61]; [@bib29]). Regulatory T cells (Tregs) have significant functions in the regulation of immune responses ([Fig. 7](#fig7){ref-type="fig"} ). Tregs can express CD4, CD25 and Foxp3, which are associated with solid tumors. The inhibiting effect of Tregs on other CD4T cells and cytotoxic CD4T cells depends on intercellular communication and the secretion of inhibitory cytokines such as transforming growth factor beta (TGF-β). TGF-β induces the expression of cyclooxygenase 2 (COX2), and the overexpression of COX2 secretes high levels of PGE2. PGE2 significantly up-regulates the expression of the Treg cell-specific transcription factor forkhead/winged helix transcription factor gene (Foxp3) in CD4^+^ and CD25^+^ T cells. Thus, the induction, maintenance and function of the Tregs are closely related to COX2-PGE2 pathway. Numerous studies have shown that *T. hemsleyanum* could decrease the expression of PGE2, COX2 and TGF-β, down-regulate the proportion of CD4^+^, CD25^+^, Foxp3^+^T and Tregs, consequently improve the immunosuppressive state of tumor patients or animals, enhance the immune function of the body and achieve the anti-tumor effect ([@bib19], [@bib20], [@bib21]; [@bib19]; [@bib123], [@bib124]; [@bib31]; [@bib123], [@bib123]; [@bib43]; [@bib26]; [@bib19]).Fig. 7The role of Treg cells, PGE2, COX2 and TGF-β in tumor cell immunity.Fig. 7

7. Toxicology {#sec7}
=============

More and more attention has been paid to the toxicological study of *T. hemsleyanum.* Jiang made a toxicological evaluation on the decoction of *T. hemsleyanum* root tuber according to the dosage for folk clinical use was 15 g/person/day, and results indicated that the oral LD~50~ of rats and mice was more than 100 g/kg and 40 g/kg, respectively ([@bib40]). Furthermore, after feeding with *T. hemsleyanum* root tuber at 6.25, 12.5 and 25.0 g/kg daily for 30 days, there was free of mortality and toxicity, which demonstrated that the long-term use of *T. hemsleyanum* root tuber was safe and non-toxic ([@bib41]). The acute toxicity test of crude extracts of *T. hemsleyanum* aerial parts showed that the maximum tolerated dose given by intragastric administration in mice could reach as high as 80.4 g/kg/d, which was equivalent to 321.6% of the daily dose of 60 kg of human body weight. During the 14 day observation period, no toxic reaction, no animal death and no other abnormal changes about blood and biochemical indexes, organ coefficient and organ pathology were found ([@bib1]). Besides, it also had been proved that the oral toxicity of *T. hemsleyanum* aerial parts formula granules was small, the maximum tolerable dose of gavage was more than 30.4 g/kg/d, and it was safe and reliable in clinical dosage ([@bib97]).

8. Conclusion and future perspectives {#sec8}
=====================================

*T. hemsleyanum* is an excellent medicinal plant containing bioactive constituents, which have been linked to its traditional application, such as anti-febrile convulsion, anti-pneumonia, anti-hepatitis, anti-upper respiratory infection, anti-asthma, anti-traumatic injury, antitumor. Available pharmacological studies on compounds and crude extracts indicated broad biological effects of *T. hemsleyanum*, providing basic evidences for traditional uses. Although the present review comprehensively summarized the knowledge on the botany, traditionally and ethnobotanical uses, phytochemistry, pharmacology and toxicity of the *T. hemsleyanum*, there are some gaps still require scientific evaluation and exploration.

First, a large number of studies focused on the verification of traditional pharmacological activities by now, while the phytochemical analysis of the assessed extract was lack, and the functional components were unknown. As is known to all, TCM generally contains extremely complicated phytochemical components, and different medicinal parts contain different kinds of chemical components. Different phytochemical profiles of herbs may result in different potencies in biological assessments, and the synergistic effect of different components may also affect their pharmacological activities. Therefore, phytochemical analyses are indispensable to determine the correlation between components and pharmacological activities with the aim of discovering promising precursors for the clinical drug development. Additionally, the lack of sample preparation method, or inaccurate use different part of TCM could result in low reproducibility of the reported pharmacological effects. Moreover, the identification of *T. hemsleyanum* has not been described in some studies and no voucher number has also been reported, so that the taxonomic validity of the voucher specimen cannot be validated. Some studies did not mention the identification methods and the detailed information (including location, collection date, developmental stage, plant or plant parts, collector, etc) of the *T. hemsleyanum*.

Second, some current findings have been assessed with some problems concerning their pharmacological methods and experimental designs. Some methods used in pharmacological activities of *T. hemsleyanum* do not have an appropriate design due to the lack of a positive control group, which makes the results less reliable. Additionally, few of the *in vitro* studies mentioned the passage number and population doubling time (PDL) of the cell line used. Regarding the tests on animal models, few study described complete data regarding compliance with regulations on the ethical treatment of experimental animals, including the institutional committee or organization that approved the design of the experiments. Furthermore, some pharmacological studies above-mentioned assessed the pharmacological activities only using a simple cell line or animal model without further investigating the underlying mechanisms of action. Moreover, the characteristic mode of "multi-component, multi-target, integrated adjustment" of TCMs urgently needs further pharmacological research to fully clarify.

Third, the reliability of *T. hemsleyanum* for treating poor joint flexure and extension, irregular menstruation of women, rheumatic arthralgia, viral meningitis, bruise and eczema has been confirmed by long-term clinical practice, but current findings are not enough to verify and elucidate these traditional uses from the perspective of modern pharmacology. Moreover, data on many aspects of *T. hemsleyanum*, such as acute and chronic toxicity, pharmacokinetics, quality control standard and the clinical value of active compositions is still limited which call for further study in order to establish safety and toxicological limits and provide guidance for clinical applications.

In conclusion, the information of *T. hemsleyanum* on the traditional usages, origin, chemical constituents, pharmacological activities, and toxicology has been comprehensively shown to make people more aware of *T. hemsleyanum* and promote its further investigation for the development of new herbal medicine and health products.
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